查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1428183

程式设计医疗设备(SaMD) 2024 年全球市场报告

Software As A Medical Device (SaMD) Global Market Report 2024
出版日期: 按订单生产 | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10个工作天内

价格
简介目录

程式设计医疗设备（SaMD）作为医疗设备市场规模预计将在未来几年快速成长。预计到 2028 年将以 25.3% 的复合年增长率 (CAGR) 增长至 748.6 亿美元。预计期间的成长与监管变化、网路安全问题、人工智慧和资料分析的进步、应对全球健康危机以及使用区块链实现信任和透明度有关。预测期内的主要趋势包括生态系统伙伴关係、技术快速过时、数位转型、新技术的取得、创新的必要性和技术进步。

医疗保健领域越来越多地采用物联网，推动了编程医疗设备(SaMD) 市场的预期成长。医疗保健中的物联网是指可以连接到线上电脑网路并存取医疗保健资讯技术系统的医疗工具和软体。物联网在医疗保健中的一个重要应用是远端患者监控。这涉及使用连接的设备和感测器来远端监控患者健康状况并收集相关资料。基于物联网的远端医疗在医疗保健领域的整合被认为是革命性的，透过实现主动干预、个人化护理、改善患者治疗结果和增强隐私来改善健康结果，它提供了彻底改变护理服务的潜力。值得注意的是，Medicon Publications 2023 年 5 月的一份报告发现，到 2021 年，80% 的美国人支持远端患者监护，到 2024 年，美国估计将有 3,000 万名患者远端患者监护技术。服务。美国疾病管制与预防中心在 2022 年 10 月透露，2021 年有 37.0% 的人使用远端医疗，其中女性（42.0%）的盛行率高于男性（31.7%）。因此，物联网在医疗保健领域的日益普及是推动 SaMD 市场成长的关键因素。

程控医疗设备(SaMD) 市场的成长要素是慢性病的增加。慢性病是持续三个月以上的长期健康状况，SaMD 透过先进的医疗解决方案实现远端监控、个人化治疗计划和及时干预来帮助管理这些状况。根据世界卫生组织 (WHO) 2023 年 9 月的数据，全球整体74% 的死亡是由于慢性病造成的，每年死亡人数为 4,100 万人。其中包括 1,790 万人因心血管疾病、930 万人因癌症、410 万人因慢性呼吸道疾病和 200 万人因糖尿病。慢性病盛行率的不断上升凸显了 SaMD 在应对医疗保健挑战方面的重要性，进一步推动了 SaMD 市场的成长。

目录

第一章执行摘要

第二章 市场特点

第三章 市场趋势与策略

第四章宏观经济情景

  • 高通膨对市场的影响
  • 乌克兰与俄罗斯战争对市场的影响
  • COVID-19 对市场的影响

第五章世界市场规模与成长

  • 全球程式设计医疗设备（SaMD）市场驱动与阻碍因素
    • 市场驱动力
    • 市场限制
  • 2018-2023 年全球程式设计医疗设备(SaMD) 市场规模、表现与成长
  • 2023-2028年、2033年全球程式设计医疗设备（SaMD）市场规模及成长预测

第六章市场区隔

  • 全球程式设计医疗设备(SaMD) 市场，按设备类型细分、实际和预测，2018-2023、2023-2028、2033
  • 穿戴式装置
  • 个人电脑和笔记型电脑
  • 智慧型手机和平板电脑
  • 全球程式设计医疗设备(SaMD) 市场，依部署方法、效能和预测细分，2018-2023、2023-2028、2033
  • 云端基础
  • 本地
  • 全球程式设计医疗设备(SaMD) 市场，按应用细分、实际和预测，2018-2023、2023-2028、2033
  • 诊断
  • 临床管理

第 7 章 区域与国家分析

  • 全球可程式医疗设备(SaMD) 市场，按地区、绩效和预测，2018-2023、2023-2028、2033
  • 全球可程式医疗设备(SaMD) 市场，依国家/地区、绩效及预测，2018-2023、2023-2028、2033

第八章亚太市场

第九章 中国市场

第十章 印度市场

第十一章 日本市场

第十二章 澳洲市场

第十三章 印尼市场

第14章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章 德国市场

第十八章 法国市场

第十九章 义大利市场

第20章 西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第25章加拿大市场

第26章 南美洲市场

第27章 巴西市场

第28章 中东市场

第29章 非洲市场

第三十章 竞争形势及公司概况

  • 程控医疗设备（SaMD）市场竞争形势
  • 软体医疗设备 (SaMD) 市场的公司概况
    • Apple Inc.
    • McKesson Corporation
    • Thermo Fisher Scientific Inc.
    • Abbott Laboratories
    • Siemens Healthcare GmbH

第31章 其他大型创新公司

  • GE HealthCare Technologies Inc.
  • Roche Diagnostics
  • 3M Health Care
  • Cerner Corporation
  • Illumina Inc.
  • Philips Medical Systems Ltd.
  • Dexcom Inc.
  • Sysmex Corporation
  • Carl Zeiss Meditec AG
  • Nihon Kohden Corporation
  • Zhlke Group
  • Viz ai Inc.
  • Paragon Biosciences LLC
  • S3 Connected Health
  • Arterys Inc.

第32章竞争基准化分析

第 33 章. 竞争对手仪表板

第三十四章 重大併购

第35章 未来前景与可能性分析

第36章附录

简介目录
Product Code: r14027

Software as a Medical Device (SaMD) encompasses software-designed devices intended for medical purposes, eliminating the need for a physical medical device. This term categorizes software applications or programs with a medical function utilized in the diagnosis, treatment, or monitoring of medical conditions.

The primary categories of devices in SaMD include wearable devices, PCs, laptops, smartphones, and tablets. Wearable devices are electronic equipment placed on or within the human body, facilitating communication with other devices to transmit or collect data. These devices can be deployed through cloud-based or on-premise solutions and find applications in diagnostic and clinical management.

The (SaMD) software as a medical device market research report is one of a series of new reports from The Business Research Company that provides (SaMD) software as a medical device market statistics, including (SaMD) software as a medical device industry global market size, regional shares, competitors with a (SaMD) software as a medical device market share, detailed (SaMD) software as a medical device market segments, market trends and opportunities, and any further data you may need to thrive in the (SaMD) software as a medical device industry. This (SaMD) software as a medical device market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The (samd) software as a medical device market size has grown exponentially in recent years. It will grow from $24.29 billion in 2023 to $30.4 billion in 2024 at a compound annual growth rate (CAGR) of 25.2%. The historical period's growth can be ascribed to factors such as globalization, increasing complexity of challenges, market dynamics, shared research and development costs, and sustainability goals.

The (samd) software as a medical device market size is expected to see exponential growth in the next few years. It will grow to $74.86 billion in 2028 at a compound annual growth rate (CAGR) of 25.3%. The forecasted period's growth is linked to regulatory changes, cybersecurity concerns, advancements in AI and data analytics, responses to global health crises, and the utilization of blockchain for trust and transparency. Key trends in the forecast period encompass ecosystem partnerships, swift technological obsolescence, digital transformation, access to new technologies, the imperative for innovation, and technological advancements.

The anticipated growth in the software as a medical device (SaMD) market is driven by the increasing adoption of IoT in the healthcare sector. IoT in healthcare refers to medical tools and software that can connect to online computer networks to access healthcare information technology systems. A crucial application of IoT in healthcare is remote patient monitoring, which involves using connected devices and sensors to remotely monitor patients' health status and collect relevant data. The integration of IoT-based telemedicine in the healthcare sector is considered innovative, offering the potential to revolutionize healthcare delivery by enabling proactive interventions, personalized care, improved patient outcomes, and enhanced privacy. Notably, a report by Medicon Publications in May 2023 indicated that 80% of Americans favored remote patient monitoring in 2021, and an estimated 30 million patients in the US are expected to utilize remote patient monitoring technologies and services by 2024. Additionally, data from the Centers for Disease Control and Prevention in October 2022 revealed that 37.0% of individuals utilized telemedicine in 2021, with higher prevalence among women (42.0%) than men (31.7%). Hence, the increasing adoption of IoT in healthcare is a key factor propelling the growth of the SaMD market.

The factor contributing to the growth of the software as a medical device (SaMD) market is the rise in chronic diseases. Chronic diseases are long-term health conditions that persist for three months or more, and SaMD plays a crucial role in managing these conditions by enabling remote monitoring, personalized treatment plans, and timely interventions through advanced healthcare solutions. According to the World Health Organization (WHO) in September 2023, chronic diseases account for 74% of all global deaths, with 41 million deaths annually. These include 17.9 million deaths from cardiovascular diseases, 9.3 million from cancer, 4.1 million from chronic respiratory diseases, and 2.0 million from diabetes. The increasing prevalence of chronic diseases underscores the significance of SaMD in addressing healthcare challenges, further driving the growth of the SaMD market.

The software as a medical device (SaMD) market is witnessing a significant trend with the increasing popularity of AI-powered software. Leading companies in the SaMD market are actively developing innovative AI-driven software solutions to maintain their market positions. For example, in May 2023, the French biotechnology company Genomic Vision launched FiberSmart, an AI-powered software designed for the automated detection and quantification of fluorescent signals on combed DNA molecules. This technology facilitates the analysis of DNA replication kinetics, streamlining the process of detecting and quantifying fluorescent signals. FiberSmart features AI-powered detection and quantification, a user-friendly interface, and scalability. It is compatible with Genomic Vision's suite of scanners and has undergone successful testing and validation.

Major players in the SaMD market are increasingly focusing on introducing advanced software, such as SOMNUM, to gain a competitive advantage. SOMNUM is a sleep disease analysis software that incorporates the latest AI research trends and diagnostic algorithms based on multi-channel sleep biosignal data, surpassing traditional video-image-based methods. In September 2023, HoneyNaps Co., Ltd., a South Korea-based software company, received approval from the United States Food and Drug Administration (USFDA) for SOMNUM software. This deep learning-based AI software offers real-time analysis of various sleep biosignals, including electroencephalograms, electrooculograms, electromyograms, electrocardiograms, respiratory airflow and effort, and oxygen saturation. SOMNUM provides more accurate and sophisticated readings than conventional methods, enabling the analysis of patient sleep data in under five minutes.

In June 2022, Greenlight Guru, a US-based software company, acquired Smart-Trial for an undisclosed amount. This strategic move is aimed at expanding Greenlight Guru's offerings, enhancing its capabilities, extending market reach, and generating additional revenue. Smart-Trial, based in Denmark, specializes in designing software for medical devices.

Major companies operating in the (samd) software as a medical device market report are Apple Inc., McKesson Corporation, Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthcare GmbH, GE HealthCare Technologies Inc., Roche Diagnostics, 3M Health Care, Cerner Corporation, Illumina Inc., Philips Medical Systems Ltd., Dexcom Inc., Sysmex Corporation, Carl Zeiss Meditec AG, Nihon Kohden Corporation, Zhlke Group, Viz ai Inc., Paragon Biosciences LLC, S3 Connected Health, Arterys Inc., BrightInsight Inc., Agfa HealthCare Corp., iSchemaView Inc., VitalConnect Inc., Volpara Health Technologies, Tietronix Software Inc., Velentium LLC, Greenfinch Technology Ltd., MaxQ AI Ltd., IDx Technologies Inc.

North America was the largest region in the software as a medical device (SaMD) market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the (samd) software as a medical device market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the (samd) software as a medical device market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The SaMD (software as a medical device) market consists of revenues earned by entities by providing diagnostic assistance, treatment planning and guidance, monitoring and remote patient management services. The market value includes the value of related goods sold by the service provider or included within the service offering. The SaMD (software as a medical device) market also includes sales of clinical decision support systems, digital diagnostics and screening tools, personal health and wellness apps, radiology imaging software, and diabetic management apps, which are used in providing SaMD (software as a medical device) services. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Software As A Medical Device (SaMD) Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on software as a medical device (samd) market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for software as a medical device (samd) ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The software as a medical device (samd) market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

  • 1) By Device Type: Wearable Device; PCs And Laptop; Smartphone And Tablets
  • 2) By Deployment Method: Cloud-Based; On-Premise
  • 3) By Application: Diagnostic; Clinical Management
  • Companies Mentioned: Apple Inc.; McKesson Corporation; Thermo Fisher Scientific Inc.; Abbott Laboratories; Siemens Healthcare GmbH
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Software As A Medical Device (SaMD) Market Characteristics

3. Software As A Medical Device (SaMD) Market Trends And Strategies

4. Software As A Medical Device (SaMD) Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Software As A Medical Device (SaMD) Market Size and Growth

  • 5.1. Global Software As A Medical Device (SaMD) Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Software As A Medical Device (SaMD) Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Software As A Medical Device (SaMD) Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Software As A Medical Device (SaMD) Market Segmentation

  • 6.1. Global Software As A Medical Device (SaMD) Market, Segmentation By Device Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Wearable Device
  • PCs And Laptop
  • Smartphone And Tablets
  • 6.2. Global Software As A Medical Device (SaMD) Market, Segmentation By Deployment Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Cloud-Based
  • On-Premise
  • 6.3. Global Software As A Medical Device (SaMD) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Diagnostic
  • Clinical Management

7. Software As A Medical Device (SaMD) Market Regional And Country Analysis

  • 7.1. Global Software As A Medical Device (SaMD) Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Software As A Medical Device (SaMD) Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Software As A Medical Device (SaMD) Market

  • 8.1. Asia-Pacific Software As A Medical Device (SaMD) Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Software As A Medical Device (SaMD) Market, Segmentation By Device Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Software As A Medical Device (SaMD) Market, Segmentation By Deployment Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Software As A Medical Device (SaMD) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Software As A Medical Device (SaMD) Market

  • 9.1. China Software As A Medical Device (SaMD) Market Overview
  • 9.2. China Software As A Medical Device (SaMD) Market, Segmentation By Device Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Software As A Medical Device (SaMD) Market, Segmentation By Deployment Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Software As A Medical Device (SaMD) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Software As A Medical Device (SaMD) Market

  • 10.1. India Software As A Medical Device (SaMD) Market, Segmentation By Device Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Software As A Medical Device (SaMD) Market, Segmentation By Deployment Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Software As A Medical Device (SaMD) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Software As A Medical Device (SaMD) Market

  • 11.1. Japan Software As A Medical Device (SaMD) Market Overview
  • 11.2. Japan Software As A Medical Device (SaMD) Market, Segmentation By Device Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Software As A Medical Device (SaMD) Market, Segmentation By Deployment Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Software As A Medical Device (SaMD) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Software As A Medical Device (SaMD) Market

  • 12.1. Australia Software As A Medical Device (SaMD) Market, Segmentation By Device Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Software As A Medical Device (SaMD) Market, Segmentation By Deployment Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Software As A Medical Device (SaMD) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Software As A Medical Device (SaMD) Market

  • 13.1. Indonesia Software As A Medical Device (SaMD) Market, Segmentation By Device Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Software As A Medical Device (SaMD) Market, Segmentation By Deployment Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Software As A Medical Device (SaMD) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Software As A Medical Device (SaMD) Market

  • 14.1. South Korea Software As A Medical Device (SaMD) Market Overview
  • 14.2. South Korea Software As A Medical Device (SaMD) Market, Segmentation By Device Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Software As A Medical Device (SaMD) Market, Segmentation By Deployment Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Software As A Medical Device (SaMD) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Software As A Medical Device (SaMD) Market

  • 15.1. Western Europe Software As A Medical Device (SaMD) Market Overview
  • 15.2. Western Europe Software As A Medical Device (SaMD) Market, Segmentation By Device Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Software As A Medical Device (SaMD) Market, Segmentation By Deployment Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Software As A Medical Device (SaMD) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Software As A Medical Device (SaMD) Market

  • 16.1. UK Software As A Medical Device (SaMD) Market, Segmentation By Device Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Software As A Medical Device (SaMD) Market, Segmentation By Deployment Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Software As A Medical Device (SaMD) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Software As A Medical Device (SaMD) Market

  • 17.1. Germany Software As A Medical Device (SaMD) Market, Segmentation By Device Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Software As A Medical Device (SaMD) Market, Segmentation By Deployment Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Software As A Medical Device (SaMD) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Software As A Medical Device (SaMD) Market

  • 18.1. France Software As A Medical Device (SaMD) Market, Segmentation By Device Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Software As A Medical Device (SaMD) Market, Segmentation By Deployment Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Software As A Medical Device (SaMD) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Software As A Medical Device (SaMD) Market

  • 19.1. Italy Software As A Medical Device (SaMD) Market, Segmentation By Device Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Software As A Medical Device (SaMD) Market, Segmentation By Deployment Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Software As A Medical Device (SaMD) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Software As A Medical Device (SaMD) Market

  • 20.1. Spain Software As A Medical Device (SaMD) Market, Segmentation By Device Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Software As A Medical Device (SaMD) Market, Segmentation By Deployment Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Software As A Medical Device (SaMD) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Software As A Medical Device (SaMD) Market

  • 21.1. Eastern Europe Software As A Medical Device (SaMD) Market Overview
  • 21.2. Eastern Europe Software As A Medical Device (SaMD) Market, Segmentation By Device Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Software As A Medical Device (SaMD) Market, Segmentation By Deployment Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Software As A Medical Device (SaMD) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Software As A Medical Device (SaMD) Market

  • 22.1. Russia Software As A Medical Device (SaMD) Market, Segmentation By Device Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Software As A Medical Device (SaMD) Market, Segmentation By Deployment Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Software As A Medical Device (SaMD) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Software As A Medical Device (SaMD) Market

  • 23.1. North America Software As A Medical Device (SaMD) Market Overview
  • 23.2. North America Software As A Medical Device (SaMD) Market, Segmentation By Device Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Software As A Medical Device (SaMD) Market, Segmentation By Deployment Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Software As A Medical Device (SaMD) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Software As A Medical Device (SaMD) Market

  • 24.1. USA Software As A Medical Device (SaMD) Market Overview
  • 24.2. USA Software As A Medical Device (SaMD) Market, Segmentation By Device Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Software As A Medical Device (SaMD) Market, Segmentation By Deployment Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Software As A Medical Device (SaMD) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Software As A Medical Device (SaMD) Market

  • 25.1. Canada Software As A Medical Device (SaMD) Market Overview
  • 25.2. Canada Software As A Medical Device (SaMD) Market, Segmentation By Device Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Software As A Medical Device (SaMD) Market, Segmentation By Deployment Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Software As A Medical Device (SaMD) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Software As A Medical Device (SaMD) Market

  • 26.1. South America Software As A Medical Device (SaMD) Market Overview
  • 26.2. South America Software As A Medical Device (SaMD) Market, Segmentation By Device Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Software As A Medical Device (SaMD) Market, Segmentation By Deployment Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Software As A Medical Device (SaMD) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Software As A Medical Device (SaMD) Market

  • 27.1. Brazil Software As A Medical Device (SaMD) Market, Segmentation By Device Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Software As A Medical Device (SaMD) Market, Segmentation By Deployment Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Software As A Medical Device (SaMD) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Software As A Medical Device (SaMD) Market

  • 28.1. Middle East Software As A Medical Device (SaMD) Market Overview
  • 28.2. Middle East Software As A Medical Device (SaMD) Market, Segmentation By Device Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Software As A Medical Device (SaMD) Market, Segmentation By Deployment Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Software As A Medical Device (SaMD) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Software As A Medical Device (SaMD) Market

  • 29.1. Africa Software As A Medical Device (SaMD) Market Overview
  • 29.2. Africa Software As A Medical Device (SaMD) Market, Segmentation By Device Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Software As A Medical Device (SaMD) Market, Segmentation By Deployment Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Software As A Medical Device (SaMD) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Software As A Medical Device (SaMD) Market Competitive Landscape And Company Profiles

  • 30.1. Software As A Medical Device (SaMD) Market Competitive Landscape
  • 30.2. Software As A Medical Device (SaMD) Market Company Profiles
    • 30.2.1. Apple Inc.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. McKesson Corporation
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Thermo Fisher Scientific Inc.
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Abbott Laboratories
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Siemens Healthcare GmbH
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Software As A Medical Device (SaMD) Market Other Major And Innovative Companies

  • 31.1. GE HealthCare Technologies Inc.
  • 31.2. Roche Diagnostics
  • 31.3. 3M Health Care
  • 31.4. Cerner Corporation
  • 31.5. Illumina Inc.
  • 31.6. Philips Medical Systems Ltd.
  • 31.7. Dexcom Inc.
  • 31.8. Sysmex Corporation
  • 31.9. Carl Zeiss Meditec AG
  • 31.10. Nihon Kohden Corporation
  • 31.11. Zhlke Group
  • 31.12. Viz ai Inc.
  • 31.13. Paragon Biosciences LLC
  • 31.14. S3 Connected Health
  • 31.15. Arterys Inc.

32. Global Software As A Medical Device (SaMD) Market Competitive Benchmarking

33. Global Software As A Medical Device (SaMD) Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Software As A Medical Device (SaMD) Market

35. Software As A Medical Device (SaMD) Market Future Outlook and Potential Analysis

  • 35.1 Software As A Medical Device (SaMD) Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Software As A Medical Device (SaMD) Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Software As A Medical Device (SaMD) Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer